Reduction of human menopausal gonadotropin dose before coasting prevents severe ovarian hyperstimulation syndrome with minimal cycle cancellation.
Aboulghar
M A
MA
Egyptian IVF-ET Center, Cairo, Egypt.
Mansour
R T
RT
Serour
G I
GI
Rhodes
C A
CA
Amin
Y M
YM
D000328:Adult; D006063:Chorionic Gonadotropin / Q000008:administration & dosage / Q000494:pharmacology; D004958:Estradiol / Q000097:blood; D005260:Female; D005306:Fertilization; D005307:Fertilization in Vitro; D006801:Humans; D008423:Maternal Age; D008596:Menotropins / Q000008:administration & dosage* / Q000494:pharmacology*; D008598:Menstruation / Q000187:drug effects*; D016471:Ovarian Hyperstimulation Syndrome / Q000139:chemically induced* / Q000517:prevention & control; D010053:Ovary / Q000187:drug effects*; D010062:Ovulation Induction / Q000009:adverse effects; D018873:Pregnancy Rate; D012307:Risk Factors; D020554:Sperm Injections, Intracytoplasmic
D006063:Chorionic Gonadotropin; D004958:Estradiol; D008596:Menotropins